Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

6.95
Delayed Data
As of Mar 27
 +0.07 / +1.02%
Today’s Change
1.95
Today|||52-Week Range
7.05
+89.37%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 7.50, with a high estimate of 7.50 and a low estimate of 7.50. The median estimate represents a +7.91% increase from the last price of 6.95.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.13
Sales
$3.2M
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 43.48%
 
 
 
 
 
 
Growthannually 2.42%
 
 
 
 
 
 

Sales

Growthquarterly 732.96%
 
 
 
 
 
 
Growthannually 549.50%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.